Literature DB >> 12928230

Regulation of serum paraoxonase activity by genetic, nutritional, and lifestyle factors in the general population.

Natàlia Ferré1, Jordi Camps, Joan Fernández-Ballart, Victoria Arija, Michelle M Murphy, Santiago Ceruelo, Elisabet Biarnés, Elisabet Vilella, Mónica Tous, Jorge Joven.   

Abstract

BACKGROUND: Paraoxonase may protect lipoproteins and cell membranes from peroxidation, and alterations in the activity of this enzyme have been associated with some chronic diseases. Serum paraoxonase appears to be mainly under genetic control, but some studies suggest that environmental factors may also modulate its activity. The aim of the present study was to investigate whether diet and lifestyle affect serum paraoxonase activity.
METHODS: We studied a population-based sample of 388 individuals (194 women and 194 men; age range, 18-75 years) and assessed their daily dietary intake using a 3-day estimated food record. The variables studied included serum paraoxonase activity, paraoxonase polymorphisms at positions 55 and 192, age, gender, smoking status, physical exercise, body mass index, energy consumption, nutrient intake (total lipids, saturated fatty acids, beta-carotenes, vitamins C and E), and serum lipid concentrations.
RESULTS: Multiple linear regression analysis showed that only genetic polymorphisms, serum cholesterol, HDL-cholesterol concentrations, and cigarette smoking were significant predictors of serum paraoxonase activity. HDL-cholesterol concentrations were also related to body mass index, daily energy consumption, and saturated fatty acid intake.
CONCLUSIONS: The between-individual variability of serum paraoxonase activity is regulated mainly by genetic determinants. Although HDL-cholesterol and tobacco smoking may contribute to the modulation of this enzyme, the other nutritional and lifestyle factors do not seem to play a significant role.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12928230     DOI: 10.1373/49.9.1491

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  32 in total

1.  Serum paraoxonase-3 concentration in HIV-infected patients. Evidence for a protective role against oxidation.

Authors:  Gerard Aragonès; Anabel García-Heredia; Marta Guardiola; Anna Rull; Raúl Beltrán-Debón; Judit Marsillach; Carlos Alonso-Villaverde; Bharti Mackness; Michael Mackness; Juan Pedro-Botet; Pedro Pardo-Reche; Jorge Joven; Jordi Camps
Journal:  J Lipid Res       Date:  2011-10-14       Impact factor: 5.922

Review 2.  Paraoxonases: metabolic role and pharmacological projection.

Authors:  Carlos Moya; Salvador Máñez
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-02-06       Impact factor: 3.000

3.  Effect of cigarette smoking on paraoxonase 1 activity according to PON1 L55M and PON1 Q192R gene polymorphisms.

Authors:  Dhouha Haj Mouhamed; Asma Ezzaher; Anwar Mechri; Fadoua Neffati; Asma Omezzine; Ali Bouslama; Lotfi Gaha; Wahiba Douki; Mohamed Fadhel Najjar
Journal:  Environ Health Prev Med       Date:  2011-12-29       Impact factor: 3.674

4.  Association of L55M and Q192R polymorphisms in paraoxonase 1 (PON1) gene with breast cancer risk and their clinical significance.

Authors:  Yousri M Hussein; Amal F Gharib; Rasha L Etewa; Wael H ElSawy
Journal:  Mol Cell Biochem       Date:  2011-01-13       Impact factor: 3.396

Review 5.  Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis.

Authors:  Emanuele D'Amico; Pam Factor-Litvak; Regina M Santella; Hiroshi Mitsumoto
Journal:  Free Radic Biol Med       Date:  2013-06-21       Impact factor: 7.376

6.  Serum paraoxonase activity and lipid hydroperoxide levels in adult football players after three days football tournament.

Authors:  M Atli
Journal:  Afr Health Sci       Date:  2013-09       Impact factor: 0.927

7.  Paraoxonase 1 polymorphisms and risk of myocardial infarction in women and men.

Authors:  Kenneth J Mukamal; Jennifer K Pai; Majken K Jensen; Eric B Rimm
Journal:  Circ J       Date:  2009-05-15       Impact factor: 2.993

8.  Developmental changes in PON1 enzyme activity in young children and effects of PON1 polymorphisms.

Authors:  Karen Huen; Kim Harley; Jordan Brooks; Alan Hubbard; Asa Bradman; Brenda Eskenazi; Nina Holland
Journal:  Environ Health Perspect       Date:  2009-06-09       Impact factor: 9.031

9.  Serum cholinesterase inhibition in relation to paraoxonase-1 (PON1) status among organophosphate-exposed agricultural pesticide handlers.

Authors:  Jonathan N Hofmann; Matthew C Keifer; Clement E Furlong; Anneclaire J De Roos; Federico M Farin; Richard A Fenske; Gerald van Belle; Harvey Checkoway
Journal:  Environ Health Perspect       Date:  2009-06-09       Impact factor: 9.031

10.  Paraoxonase gene polymorphism in south-western Korean population.

Authors:  Byoung-Soo Shin
Journal:  J Korean Med Sci       Date:  2009-07-29       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.